Zelira Therapeutics Limited [ASX:ZLD] share price and news 2022

Company Description

Zelira Therapeutics Limited (ZLD, formerly Zelda Therapeutics Limited) is an Australian-based bio-pharmaceutical company that is focused on developing a range of cannabinoid-based formulations for the treatment of a variety of medical conditions.

Zelira Therapeutics Limited belongs to Health Care sector and under industry of Pharmaceuticals. You can get more information about this company via their website: http://www.zeliratx.com.

This a small cap company with market cap of 76 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is less than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 1.79 0
Market 0.85 22.3 1.99 0.84
Sector 1.7 39.6 5.78 0.26

Dividend Growth Chart

The following chart shows you how zld dividend grows in the recent years.

No data